Skip to main content

Exousia Bio, Inc 10-Q for FY2024 Q2

Exousia Bio, Inc. (LMMY)

10-Q 2024-01-16 For: 2023-11-30
View Original
Added on April 06, 2026

About this 10-Q

Exousia Bio, Inc filed this 10-Q on January 16, 2024, covering the quarter ended November 30, 2023 (FY2024 Q2).

Headline figures

Quarter ended November 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$3875
compared with $0 a year earlier
Net loss
$3573
compared with a net loss of $8407 a year earlier
Diluted EPS
$0.00
compared with $0.00 a year earlier